Adverum Biotechnologies, Inc. (ADVM) Ownership

$2.23

$0.02 (-0.89%)
Last update: 04:00 PM EST
Day's range
$2.14
Day's range
$2.36

Adverum Biotechnologies, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BML CAPITAL MANAGEMENT, LLC 05/07/2025 2.74 M $11.98 M   20.91% 13.10%
TCG CROSSOVER MANAGEMENT, LLC 05/14/2025 1.80 M $7.85 M   0.00% 8.58%
FRANKLIN RESOURCES INC 05/13/2025 1.76 M $7.69 M   0.00% 8.41%
04/11/2025 1.70 M $6.07 M   27.52% 8.10%
BLACKROCK, INC. 05/02/2025 1.43 M $6.24 M   -3.93% 6.81%
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 05/15/2025 1.07 M $4.67 M   0.00% 5.11%
VANGUARD GROUP INC 05/09/2025 1.03 M $4.50 M   -0.17% 4.92%
GOLDMAN SACHS GROUP INC 05/16/2025 460.83 K $2.01 M   -7.96% 2.20%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 451.26 K $1.97 M   1.98% 2.16%
PALE FIRE CAPITAL SE 05/14/2025 368.27 K $1.61 M   16.85% 1.76%
STATE STREET CORP 05/15/2025 363.97 K $1.59 M   -1.51% 1.74%
DIMENSIONAL FUND ADVISORS LP 05/13/2025 287.79 K $1.26 M   -7.46% 1.37%
SOLEUS CAPITAL MANAGEMENT, L.P. 05/15/2025 287.25 K $1.26 M   0.00% 1.37%
REGENERON PHARMACEUTICALS, INC. 05/02/2025 180.91 K $790.57 K   0.00% 0.86%
WAVERLY ADVISORS, LLC 05/15/2025 160.17 K $699.92 K   100.00% 0.76%
GRANT/GROSSMENDELSOHN, LLC 05/01/2025 160.16 K $461.25 K   90.27% 0.76%
RENAISSANCE TECHNOLOGIES LLC 05/14/2025 159.57 K $697.32 K   23.12% 0.76%
NORTHERN TRUST CORP 05/13/2025 150.37 K $657.13 K   -1.45% 0.72%
MORGAN STANLEY 05/15/2025 68.72 K $300.30 K   -40.14% 0.33%
UBS GROUP AG 05/13/2025 57.55 K $251.49 K   20.91% 0.27%
BANK OF AMERICA CORP /DE/ 05/15/2025 51.22 K $223.84 K   17.55% 0.24%
INVESCO LTD. 05/12/2025 49.83 K $217.76 K   100.00% 0.24%
BANK OF NEW YORK MELLON CORP 04/29/2025 49.32 K $215.55 K   2.05% 0.24%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 49.02 K $214.24 K   -17.93% 0.23%
QUINN OPPORTUNITY PARTNERS LLC 05/14/2025 41.42 K $181.00 K   54.38% 0.20%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 37.33 K $163.15 K   100.00% 0.18%
AQR CAPITAL MANAGEMENT LLC 05/15/2025 33.82 K $147.81 K   100.00% 0.16%
RHUMBLINE ADVISERS 05/29/2025 33.00 K $144.20 K   4.21% 0.16%
05/12/2025 31.85 K $139.17 K   100.00% 0.15%
BARCLAYS PLC 05/15/2025 29.51 K $129.00 K   -26.02% 0.14%
D. E. SHAW & CO., INC. 05/15/2025 26.94 K $117.75 K   -43.41% 0.13%
TREXQUANT INVESTMENT LP 05/14/2025 18.69 K $81.69 K   -80.53% 0.09%
AMERICAN CENTURY COMPANIES INC 05/13/2025 17.65 K $77.12 K   8.42% 0.08%
CANTOR FITZGERALD, L. P. 05/15/2025 15.45 K $67.50 K   0.00% 0.07%
CITIGROUP INC 05/12/2025 14.75 K $64.47 K   -26.19% 0.07%
FMR LLC 05/12/2025 13.47 K $58.86 K   -76.74% 0.06%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 05/15/2025 12.62 K $55.14 K   4.52% 0.06%
WELLS FARGO & COMPANY/MN 05/13/2025 12.53 K $54.76 K   2.38% 0.06%
INTECH INVESTMENT MANAGEMENT LLC 05/20/2025 12.40 K $54.19 K   100.00% 0.06%
CAPTRUST FINANCIAL ADVISORS 05/15/2025 10.62 K $46.43 K   100.00% 0.05%
JPMORGAN CHASE & CO 05/12/2025 10.20 K $44.57 K   -66.74% 0.05%
COREBRIDGE FINANCIAL, INC. 05/14/2025 10.19 K $44.54 K   -1.46% 0.05%
CITADEL ADVISORS LLC 05/15/2025 7.60 K $33.21 K   -25.49% 0.04%
CITADEL ADVISORS LLC 05/15/2025 6.10 K $26.66 K   -36.46% 0.03%
SIMPLEX TRADING, LLC 05/12/2025 4.31 K $18.00 K   116.30% 0.02%
05/09/2025 4.18 K $18.28 K   0.00% 0.02%
NEW YORK STATE COMMON RETIREMENT FUND 05/01/2025 3.00 K $13.00 K   0.00% 0.01%
ROYAL BANK OF CANADA 05/15/2025 2.55 K $11.00 K   -28.21% 0.01%
TOWER RESEARCH CAPITAL LLC (TRC) 05/15/2025 2.40 K $10.11 K   -44.93% 0.01%
AMERITAS INVESTMENT PARTNERS, INC. 05/12/2025 2.04 K $8.91 K   0.00% 0.01%

Adverum Biotechnologies, Inc. institutional Ownership - FAQ's

During the previous two years, 101 institutional investors and hedge funds held shares of Adverum Biotechnologies, Inc.. The most heavily invested institutionals were:

BML Capital Management, LLC: 2.74 M

TCG Crossover Management, LLC: 1.8 M

FRANKLIN RESOURCES INC: 1.76 M

BlackRock, Inc.: 1.43 M

Frazier Life Sciences Management, L.P.: 1.07 M

VANGUARD GROUP INC: 1.03 M

73.02% of Adverum Biotechnologies, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 31.42 M shares in the last 24 months. This purchase volume represents approximately $70.07 M in transactions.